integrin alpha2-targeting antibodies (University of Michigan/Resonant Therapeutics)

N/A

Report date: 2025/06/11 11:03:48

Base Information

Drug Nameintegrin alpha2-targeting antibodies (University of Michigan/Resonant Therapeutics)
Drug Alias NamemAb 4C3RT-00001RT-4C3
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionMetastasis inhibitorsIntegrin alpha-2 antagonists
TargetsIntegrin alpha-2
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesResonant Therapeutics IncUniversity Of Michigan
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A